CD19 and acute lymphoblastic leukemia: Skipping of exon 2 during processing of the CD19 pre-mRNA (leading to the formation of the CD19-∆2 variant) results in an N-terminally truncated CD19 protein lacking the CAR recognition site, which prevents CAR T-cell targeting/killing of B-ALL cells [127].